Accolade vs Nava Benefits

Side-by-side comparison of model-estimated upside.

Accolade

-64%

est. 2Y upside i

Healthcare

Rank

#3746

Sector

Healthcare Technology

Est. Liquidity

~3Y

Data Quality

Data: High

The equity opportunity in Transcarent (post-Accolade acquisition) is risky, with an expected upside of 7% over a two-year horizon.

Last updated: March 10, 2026

Nava Benefits

-49%

est. 2Y upside i

InsurTechHR TechSeries C

Rank

#1134

Sector

Insurtech, HR Tech

Est. Liquidity

~3Y

Data Quality

Data: Medium

Nava Benefits presents a moderate upside opportunity with an estimated 80% expected return over two years, driven by strong customer growth (160% YoY customer logos) and the recent launch of its AI-powered HQ platform.

Last updated: March 10, 2026

Upside Comparison

Expected Upside

Accolade

-64%

Nava Benefits

-49%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.